Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans
Clinical trial NCT03776786 · COMPLETED
Trial details
- NCT number
- NCT03776786
- Sponsor
- Tysana Pte Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2019-07-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.